Article/items published online ahead of print or online only
Latest Entry: Ribociclib Improved PFS in Hormone Receptor-Positive Breast Cancer
12/8/2017 Investigational PARP Inhibitor Talazoparib Shows Clinical Benefit in EMBRACA Phase III Trial
FDA ACTIONS & UPDATES
The latest approvals, designations, and new indications from the U.S. Food and Drug Administration for oncology drugs.
Latest Entry: FDA Approves First Biosimilar for the Treatment of Certain Breast & Stomach Cancers
MUSINGS OF A CANCER DOCTOR
By George W. Sledge, Jr., MD
Observations, ponderings, and views...
3 QUESTIONS ON...
Answers straight from the experts on the latest news and topics in oncology.
Latest Entry: The Risk of Choosing Alternative Over Conventional Therapies
August 25th, 2016 - Volume 38 - FOCUS: Renal Cell Carcinoma Treatment & Research Updates 16
August 25th, 2016
July 10th, 2016 - Volume 38 - FOCUS: Renal Cell Carcinoma Treatment & Research Updates 13
February 10th, 2013 - Volume 35 - SABCS Meeting Reporter Special Edition Supplement
All the latest news,
plus a look back at
OT's comprehensive coverage on...
VIDEO: Why Did You Become an Oncologist?
And for more topics in oncology, browse our full list of
Exclusive interviews and perspectives from our iPad archives
Most Recently Added: "How Health IT is Changing Oncology"—Andrew Zelenetz, MD, PhD, Chief of the Lymphoma Service and Vice Chair of Medical Informatics at Memorial Sloan Kettering Cancer Center, tells OT how oncologists there are training a computer to understand and compare big data sets...